Safilo Group delivered solid QQ2 2025 results with revenue of EUR 268.8 million and a gross profit of EUR 164.1 million, yielding a gross margin of approximately 61.05%. Operating income reached EUR 25.6 million, translating to an operating margin near 9.54%, while net income stood at EUR 20.9 million and basic earnings per share at EUR 0.050. The quarter showcased meaningful margin discipline and revenue scale consistent with Safilo’s brand portfolio and distribution reach, supporting a constructive read on profitability cadence even as the business cycles through seasonality and channel dynamics. The reported metrics imply meaningful operating leverage as the company scales, with EBITDA of EUR 32.66 million and a cash-generative profile reflected in CFO per share of EUR 0.0975 and free cash flow per share of EUR 0.0906. Balance sheet metrics remain conservative, underpinned by manageable leverage and solid liquidity, with current ratio of 1.86 and debt-to-capitalization at 0.223. While management guidance is not disclosed in the provided data, the quarter reinforces the appeal of Safilo’s diversified brand portfolio in the healthcare eyewear space and the potential for further margin expansion as top-line growth normalizes and fixed costs scale.